Altimmune Inc. (United States) is listed on the Nasdaq and has a market capitalization of $323.64 Millions, with shareholders equity totaling $283.99 Millions.
The company employs approximately 43 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Altimmune Inc. reported $30.00 Thousand in revenue, generating net income of $-91.08 Millions.
Key financial metrics include a P/E ratio of -3.55, a price-to-book (P/B) ratio of 1.14, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ALT.